Sumitomo Pharma Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DNPUF research report →
About the company
Sumitomo Pharma Co. , Ltd. is a global enterprise specializing in the manufacturing and distribution of a diverse portfolio of products, including pharmaceuticals, food ingredients and additives, chemical product materials, and veterinary medicines.
- CEO
- Toru Kimura
- IPO
- 2012
- Employees
- 4,980
- HQ
- Osaka, JP
Price Chart
- Market Cap
- $4.22B
- P/E
- 5.79
- P/S
- 1.54
- P/B
- 2.12
- EV/EBITDA
- 6.42
- Div Yield
- 0.00%
- Gross Margin
- 56.67%
- Op Margin
- 11.11%
- Net Margin
- 23.58%
- ROE
- 41.78%
- ROIC
- 8.81%
- Revenue
- $456.15B · 14.37%
- Net Income
- $107.54B · 355.01%
- EPS
- $270.03 · 353.91%
- Op Income
- $50.66B
- FCF YoY
- 1846.06%
- 52W High
- $19.20
- 52W Low
- $6.34
- 50D MA
- $10.23
- 200D MA
- $12.65
- Beta
- 0.48
- Avg Volume
- 140
Get TickerSpark's AI analysis on DNPUF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our DNPUF coverage
Recent articles, reports, and earnings notes.
No research on DNPUF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DNPUF report →Similar companies
Peers in the same neighborhood.